Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Orphanet Journal of Rare Diseases
Published in: Orphanet Journal of Rare Diseases 1/2022

Open Access 01-12-2022 | Epilepsy | Research

Identification of immune-infiltrated hub genes as potential biomarkers of Moyamoya disease by bioinformatics analysis

Authors: Fa Jin, Chuanzhi Duan

Published in: Orphanet Journal of Rare Diseases | Issue 1/2022

Login to get access

Abstract

Background

Moyamoya disease (MMD) is a rare chronic progressive cerebrovascular disease. Recent studies have shown that autoimmune inflammation may also be an important pathology in MMD but the molecular mechanisms of inflammation in this disease are still large unknown. This study was designed to identify key biomarkers and the immune infiltration in vessel tissue of MMD using bioinformatics analysis.

Methods

Raw gene expression profiles (GSE157628, GSE141024) were downloaded from the Gene Expression Omnibus (GEO) database, identified differentially expressed genes (DEGs) and performed functional enrichment analysis. The CIBERSORT deconvolution algorithm was used to analyze the proportion of immune cells between MMD and an MMD-negative control group. We screened for neutrophil-associated DEGs, constructed a protein–protein interaction network (PPI) using STRING, and clarified the gene cluster using the Cytoscape plugin MCODE analysis. The receiver operating characteristic (ROC) curve was applied to test and filter the best gene signature.

Results

A total of 570 DEGs were detected, including 212 downregulated and 358 up-regulated genes. Reactome and KEGG enrichment revealed that DEGs were involved in the cell cycle, molecular transport, and metabolic pathways. The immune infiltration profile demonstrated that MMD cerebrovascular tissues contained a higher proportion of neutrophils, monocytes, and natural killer cells in MMD than in controls. The PPI network and MCODE cluster identified nine DEGs (UNC13D, AZU1, PYCARD, ELANE, SDCBP, CCL11, CCL15, CCL20, and CXCL5) associated with neutrophil infiltration. ROC results showed that UNC13D has good specificity and sensitivity (AUC = 0.7846).

Conclusions

The characteristics of immune infiltration in the cerebrovascular tissues of MMD patients and abnormal expression of hub genes provide new insights for understanding MMD progression. UNC13D is shows promise as a candidate molecule to determine neutrophil infiltration characteristics in MMD.
Appendix
Available only for authorised users
Literature
1.
Suzuki J, Takaku A. Cerebrovascular, “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288–99.PubMedCrossRef
2.
Mertens R, Graupera M, Gerhardt H, Bersano A, Tournier-Lasserve E, Mensah MA, et al. The genetic basis of moyamoya disease. Transl Stroke Res. 2021;13:25–45.PubMedPubMedCentralCrossRef
3.
4.
Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of Moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo). 2012;52:245–66.CrossRef
5.
Acker G, Goerdes S, Schneider UC, Schmiedek P, Czabanka M, Vajkoczy P. Distinct clinical and radiographic characteristics of Moyamoya disease amongst European Caucasians. Eur J Neurol. 2015;22:1012–7.PubMedCrossRef
6.
Bower RS, Mallory GW, Nwojo M, Kudva YC, Flemming KD, Meyer FB. Moyamoya disease in a primarily white, midwestern US population: increased prevalence of autoimmune disease. Stroke. 2013;44:1997–9.PubMedCrossRef
7.
Kim SJ, Heo KG, Shin HY, Bang OY, Kim G-M, Chung C-S, et al. Association of thyroid autoantibodies with Moyamoya-type cerebrovascular disease: a prospective study. Stroke. 2010;41:173–6.PubMedCrossRef
8.
Watanabe C, Oishi T, Yamamoto T, Sasaki K, Tosaka M, Sato T, et al. Chorea and Broca aphasia induced by diabetic ketoacidosis in a type 1 diabetic patient diagnosed as Moyamoya disease. Diabetes Res Clin Pract. 2005;67:180–5.PubMedCrossRef
9.
Suzuki J, Kodama N. Moyamoya disease: a review. Stroke Am Heart Assoc. 1983;14:104–9.
10.
Wang X, Wang Y, Nie F, Li Q, Zhang K, Liu M, et al. Association of genetic variants with Moyamoya disease in 13 000 individuals. Stroke Am Heart Assoc. 2020;51:1647–55.
11.
Seol HJ, Wang K-C, Kim S-K, Hwang Y-S, Kim KJ, Cho B-K. Familial occurrence of moyamoya disease: a clinical study. Childs Nerv Syst. 2006;22:1143–8.PubMedCrossRef
12.
Koc F, Yerdelen D, Koc Z. Neurofibromatosis type 1 association with moyamoya disease. Int J Neurosci. 2008;118:1157–63.PubMedCrossRef
13.
Fukuyama Y, Osawa M, Kanai N. Moyamoya disease (syndrome) and the down syndrome. Brain Dev. 1992;14:254–6.PubMedCrossRef
14.
Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011;56:34–40.PubMedCrossRef
15.
Guo D-C, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, Johnson RJ, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet. 2009;84:617–27.PubMedPubMedCentralCrossRef
16.
Roder C, Peters V, Kasuya H, Nishizawa T, Takehara Y, Berg D, et al. Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients. Acta Neurochir (Wien). 2010;152:2153–60.CrossRef
17.
18.
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.PubMedPubMedCentralCrossRef
19.
20.
Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.PubMedPubMedCentralCrossRef
21.
22.
von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 2003;31:258–61.CrossRef
23.
Bader GD, Hogue CWV. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinform. 2003;4:2.CrossRef
24.
Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12:77.CrossRef
25.
26.
27.
Bekelis K, Kerley-Hamilton JS, Teegarden A, Tomlinson CR, Kuintzle R, Simmons N, et al. MicroRNA and gene expression changes in unruptured human cerebral aneurysms. J Neurosurg. 2016;125:1390–9.PubMedPubMedCentralCrossRef
28.
Sigdel TK, Shoemaker LD, Chen R, Li L, Butte AJ, Sarwal MM, et al. Immune response profiling identifies autoantibodies specific to Moyamoya patients. Orphanet J Rare Dis. 2013;8:45.PubMedPubMedCentralCrossRef
29.
Wang C, Zhao M, Wang J, Zhang D, Wang S, Zhao J. Expression analysis of transfer RNA-derived fragments in the blood of patients with moyamoya disease: a preliminary study. Mol Med Rep. 2019;19:3564–74.PubMedPubMedCentral
30.
Zhao M, Gao F, Zhang D, Wang S, Zhang Y, Wang R, et al. Altered expression of circular RNAs in Moyamoya disease. J Neurol Sci. 2017;381:25–31.PubMedCrossRef
31.
Wang W, Gao F, Zhao Z, Wang H, Zhang L, Zhang D, et al. Integrated analysis of LncRNA-mRNA co-expression profiles in patients with Moyamoya disease. Sci Rep. 2017;7:42421.PubMedPubMedCentralCrossRef
32.
Wang G, Wen Y, Faleti OD, Zhao Q, Liu J, Zhang G, et al. A panel of exosome-derived miRNAs of cerebrospinal fluid for the diagnosis of Moyamoya disease. Front Neurosci. 2020;14:548278.PubMedPubMedCentralCrossRef
33.
Nakamura K, Yanaka K, Ihara S, Nose T. Multiple intracranial arterial stenoses around the circle of Willis in association with Graves’ disease: report of two cases. Neurosurgery. 2003;53:1210–4.PubMedCrossRef
34.
Inaba M, Henmi Y, Kumeda Y, Ueda M, Nagata M, Emoto M, et al. Increased stiffness in common carotid artery in hyperthyroid Graves’ disease patients. Biomed Pharmacother. 2002;56:241–6.PubMedCrossRef
35.
Masuda J, Ogata J, Yutani C. Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in Moyamoya disease. Stroke. 1993;24:1960–7.PubMedCrossRef
36.
Martinod K, Demers M, Fuchs TA, Wong SL, Brill A, Gallant M, et al. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. Proc Natl Acad Sci U S A. 2013;110:8674–9.PubMedPubMedCentralCrossRef
37.
Seignez C, Phillipson M. The multitasking neutrophils and their involvement in angiogenesis. Curr Opin Hematol. 2017;24:3–8.PubMedCrossRef
38.
Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18:134–47.PubMedCrossRef
39.
Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, Nacken W, et al. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 2009;5:e1000639.PubMedPubMedCentralCrossRef
40.
Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. 2007;176:231–41.PubMedPubMedCentralCrossRef
41.
Rossaint J, Kühne K, Skupski J, Van Aken H, Looney MR, Hidalgo A, et al. Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response. Nat Commun. 2016;7:13464.PubMedPubMedCentralCrossRef
42.
Etulain J, Martinod K, Wong SL, Cifuni SM, Schattner M, Wagner DD. P-selectin promotes neutrophil extracellular trap formation in mice. Blood. 2015;126:242–6.PubMedPubMedCentralCrossRef
43.
von Brühl M-L, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med. 2012;209:819–35.CrossRef
44.
Tecchio C, Cassatella MA. Neutrophil-derived cytokines involved in physiological and pathological angiogenesis. Chem Immunol Allergy. 2014;99:123–37.PubMedCrossRef
45.
46.
Galgano D, Soheili T, Voss M, Torralba-Raga L, Tesi B, Cichocki F, et al. Alternative UNC13D promoter encodes a functional Munc13-4 isoform predominantly expressed in lymphocytes and platelets. Front Immunol. 2020;11:1154.PubMedPubMedCentralCrossRef
47.
Messenger SW, Woo SS, Sun Z, Martin TFJ. A Ca2+-stimulated exosome release pathway in cancer cells is regulated by Munc13-4. J Cell Biol. 2018;217:2877–90.PubMedPubMedCentralCrossRef
48.
Mollinedo F. Neutrophil degranulation, plasticity, and cancer metastasis. Trends Immunol. 2019;40:228–42.PubMedCrossRef
Metadata
Title
Identification of immune-infiltrated hub genes as potential biomarkers of Moyamoya disease by bioinformatics analysis
Authors
Fa Jin
Chuanzhi Duan
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2022
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-022-02238-4

Other articles of this Issue 1/2022

Orphanet Journal of Rare Diseases 1/2022 Go to the issue

Research

Current attitudes and preconceptions on newborn genetic screening in the Chinese reproductive-aged population

Position statement

Rare disease education in Europe and beyond: time to act

Research

Annual prevalence estimation of lymphatic malformation with a cutaneous component: observational study of a national representative sample of physicians

Research

Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia

Review

The health-related quality of life, mental health and mental illnesses of patients with inclusion body myositis (IBM): results of a mixed methods systematic review

Research

Postmarketing safety of orphan drugs: a longitudinal analysis of the US Food and Drug Administration database between 1999 and 2018